Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023

SELL
$193.75 - $232.55 $56,381 - $67,672
-291 Reduced 10.91%
2,377 $553,000
Q4 2022

Feb 02, 2023

SELL
$187.24 - $242.74 $25,277 - $32,769
-135 Reduced 4.82%
2,668 $539,000
Q3 2022

Nov 15, 2022

BUY
$177.23 - $227.44 $188,927 - $242,451
1,066 Added 61.37%
2,803 $535,000
Q2 2022

Aug 04, 2022

SELL
$181.58 - $368.0 $50,479 - $102,304
-278 Reduced 13.8%
1,737 $320,000
Q1 2022

May 02, 2022

BUY
$303.87 - $423.8 $299,008 - $417,019
984 Added 95.44%
2,015 $704,000
Q4 2021

Jan 24, 2022

SELL
$347.28 - $421.83 $544,187 - $661,007
-1,567 Reduced 60.32%
1,031 $392,000
Q3 2021

Oct 12, 2021

BUY
$405.61 - $524.84 $405 - $524
1 Added 0.04%
2,598 $1.05 Million
Q2 2021

Jul 28, 2021

BUY
$372.84 - $481.5 $707,650 - $913,887
1,898 Added 271.53%
2,597 $1.23 Million
Q1 2021

May 07, 2021

SELL
$361.28 - $504.76 $62,501 - $87,323
-173 Reduced 19.84%
699 $268,000
Q4 2020

Jan 21, 2021

SELL
$292.7 - $370.96 $672,917 - $852,837
-2,299 Reduced 72.5%
872 $323,000
Q3 2020

Oct 29, 2020

BUY
$268.51 - $400.74 $334,026 - $498,520
1,244 Added 64.56%
3,171 $980,000
Q2 2020

Jul 21, 2020

BUY
$256.46 - $373.01 $96,685 - $140,624
377 Added 24.32%
1,927 $714,000
Q1 2020

Apr 13, 2020

BUY
$209.2 - $335.53 $79,077 - $126,830
378 Added 32.25%
1,550 $423,000
Q4 2019

Jan 06, 2020

BUY
$288.29 - $335.49 $17,873 - $20,800
62 Added 5.59%
1,172 $389,000
Q3 2019

Oct 10, 2019

BUY
$266.84 - $378.23 $111,539 - $158,100
418 Added 60.4%
1,110 $338,000
Q2 2019

Jul 15, 2019

SELL
$300.59 - $368.15 $73,343 - $89,828
-244 Reduced 26.07%
692 $255,000
Q1 2019

Jun 10, 2019

BUY
$272.57 - $321.18 $255,125 - $300,624
936 New
936 $291,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Altfest L J & CO Inc Portfolio

Follow Altfest L J & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.